A detailed history of Cibc Asset Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Cibc Asset Management Inc holds 1,065,338 shares of PFE stock, worth $27.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,065,338
Previous 1,003,350 6.18%
Holding current value
$27.6 Million
Previous $28.1 Million 9.82%
% of portfolio
0.11%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$27.7 - $31.39 $1.72 Million - $1.95 Million
61,988 Added 6.18%
1,065,338 $30.8 Million
Q2 2024

Aug 01, 2024

SELL
$25.26 - $29.6 $22.5 Million - $26.4 Million
-892,648 Reduced 47.08%
1,003,350 $28.1 Million
Q1 2024

May 09, 2024

BUY
$25.89 - $29.73 $102,058 - $117,195
3,942 Added 0.21%
1,895,998 $52.6 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $3.07 Million - $3.99 Million
-117,448 Reduced 5.84%
1,892,056 $54.5 Million
Q3 2023

Oct 30, 2023

BUY
$32.09 - $37.51 $1.28 Million - $1.5 Million
39,946 Added 2.03%
2,009,504 $66.7 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $7.78 Million - $9 Million
215,373 Added 12.28%
1,969,558 $72.2 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $5.08 Million - $6.62 Million
128,999 Added 7.94%
1,754,185 $71.6 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $1.8 Million - $2.35 Million
43,150 Added 2.73%
1,625,186 $83.3 Million
Q3 2022

Nov 03, 2022

BUY
$43.76 - $53.42 $36.6 Million - $44.7 Million
836,997 Added 112.34%
1,582,036 $69.2 Million
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $1.62 Million - $1.92 Million
34,734 Added 4.89%
745,039 $39.1 Million
Q1 2022

May 06, 2022

BUY
$45.75 - $56.69 $2.58 Million - $3.2 Million
56,462 Added 8.64%
710,305 $36.8 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $7.7 Million - $11.4 Million
-186,468 Reduced 22.19%
653,843 $38.6 Million
Q3 2021

Nov 09, 2021

SELL
$39.25 - $50.42 $4.7 Million - $6.04 Million
-119,747 Reduced 12.47%
840,311 $36.1 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $88,123 - $99,828
-2,454 Reduced 0.25%
960,058 $37.6 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $1.39 Million - $1.56 Million
41,359 Added 4.49%
962,512 $34.9 Million
Q4 2020

Feb 03, 2021

SELL
$33.47 - $42.56 $1.43 Million - $1.82 Million
-42,855 Reduced 4.45%
921,153 $33.9 Million
Q3 2020

Nov 05, 2020

BUY
$31.75 - $37.25 $867,949 - $1.02 Million
27,337 Added 2.92%
964,008 $35.4 Million
Q2 2020

Jul 28, 2020

BUY
$30.12 - $36.54 $6.87 Million - $8.33 Million
227,943 Added 32.16%
936,671 $30.6 Million
Q1 2020

Apr 30, 2020

SELL
$27.03 - $38.62 $431,993 - $617,224
-15,982 Reduced 2.21%
708,728 $23.1 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $1.45 Million - $1.64 Million
43,933 Added 6.45%
724,710 $28.4 Million
Q3 2019

Oct 30, 2019

BUY
$32.49 - $42.13 $3.32 Million - $4.31 Million
102,277 Added 17.68%
680,777 $24.5 Million
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $612,203 - $687,363
16,555 Added 2.95%
578,500 $25.1 Million
Q1 2019

May 06, 2019

BUY
$37.5 - $41.2 $268,762 - $295,280
7,167 Added 1.29%
561,945 $23.9 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $2.42 Million - $2.76 Million
-63,016 Reduced 10.2%
554,778 $24.2 Million
Q3 2018

Nov 02, 2018

BUY
$34.47 - $41.81 $166,214 - $201,607
4,822 Added 0.79%
617,794 $27.2 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $1.27 Million - $1.35 Million
38,416 Added 6.69%
612,972 $22.2 Million
Q1 2018

Apr 30, 2018

SELL
$31.91 - $37.02 $899,766 - $1.04 Million
-28,197 Reduced 4.68%
574,556 $20.4 Million
Q4 2017

Feb 02, 2018

SELL
$33.26 - $35.29 $12.4 Million - $13.2 Million
-373,619 Reduced 38.27%
602,753 $21.8 Million
Q3 2017

Nov 06, 2017

BUY
$31.0 - $34.15 $30.3 Million - $33.3 Million
976,372
976,372 $34.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.